Clostridium butyricum upregulates GPR109A/AMPK/PGC-1α and ameliorates acute pancreatitis-associated intestinal barrier injury in mice
Archives of Microbiology · 2024-06 · 206 (6)
DOI: 10.1007/s00203-024-04001-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, online erschienen am 18.05.2024. Verfasst von Guiqing Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China. Hauptthemen laut MEDLINE: Clostridium butyricum, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Receptors, G-Protein-Coupled, Pancreatitis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the National Natural Science Foundation of Guangdong Province, the Guangzhou Technology Projects.
Abstract (Originalsprache)
Acute pancreatitis frequently causes intestinal barrier damage, which aggravates pancreatitis. Although Clostridium butyricum exerts anti-inflammatory and protective effects on the intestinal barrier during acute pancreatitis, the underlying mechanism is unclear. The G protein-coupled receptors 109 A (GPR109A) and adenosine monophosphate-activated protein kinase (AMPK)/ peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1α) signaling pathways can potentially influence the integrity of the intestinal barrier. Our study generated acute pancreatitis mouse models via intraperitoneal injection of cerulein and lipopolysaccharides. After intervention with Clostridium butyricum, the model mice showed reduced small intestinal and colonic intestinal barrier damage, dysbiosis amelioration, and increased GPR109A/AMPK/PGC-1α expression. In conclusion, Clostridium butyricum could improve pancreatic and intestinal inflammation and pancreatic injury, and relieve acute pancreatitis-induced intestinal barrier damage in the small intestine and colon, which may be associated with GPR109A/AMPK/PGC-1α.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China.
- Department of Gastroenterology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China. 16623111956@163.com.
- Department of Gastroenterology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, 510180, China.
Förderung
- the National Natural Science Foundation of China
- the National Natural Science Foundation of Guangdong Province
- the Guangzhou Technology Projects
Zitieren
APA
Deng, G., Wen, B., Jia, L., Liu, J., & Yan, Q. (2024). Clostridium butyricum upregulates GPR109A/AMPK/PGC-1α and ameliorates acute pancreatitis-associated intestinal barrier injury in mice. Archives of Microbiology, 206(6). https://doi.org/10.1007/s00203-024-04001-8
Vancouver
Deng G, Wen B, Jia L, Liu J, Yan Q. Clostridium butyricum upregulates GPR109A/AMPK/PGC-1α and ameliorates acute pancreatitis-associated intestinal barrier injury in mice. Archives of Microbiology. 2024;206(6). doi:10.1007/s00203-024-04001-8
BibTeX
@article{Deng2024,
author = {Deng, Guiqing and Wen, Biyan and Jia, Lin and Liu, Jiaxin and Yan, Qingqing},
title = {Clostridium butyricum upregulates GPR109A/AMPK/PGC-1α and ameliorates acute pancreatitis-associated intestinal barrier injury in mice},
journal = {Archives of Microbiology},
year = {2024},
volume = {206},
number = {6},
doi = {10.1007/s00203-024-04001-8}
}
EUVIMED